EUVIMEDEUVIMED entdecken
Crossref

Facile synthesis of Silicalite-1 with tunable porous architectures via desilication-recrystallization: Enhanced Doxorubicin delivery and inhibited growth against colorectal cancer

Wenjing Li, Juan Shao, Chuxin Zhang, Guodong Cao, Yitao Yan, Qiongyi Han, Huimei Yu, Yingying Wei, Wenbo Zhang, Jie Zheng, Zhongyuan Guo

Colloids and Surfaces B: Biointerfaces · 2026-01 · 257 · 115136

DOI: 10.1016/j.colsurfb.2025.115136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Colloids and Surfaces B: Biointerfaces, 2026-01. Verfasst von Wenjing Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Medical Sciences, Shanxi Medical University, Jinzhong 030600, PR China. Hauptthemen laut MEDLINE: Doxorubicin, Colorectal Neoplasms, Silicates, Antibiotics, Antineoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Shanxi Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer has emerged as a leading cause of global cancer-related morbidity and mortality, necessitating innovative therapeutic strategies. We developed a desilication-recrystallization method to synthesize Silicalite-1-X (X = 2, 8, 16, 32), a hierarchical porous silica molecular sieve with cost-effectiveness, facile synthesis, and tunable porosity. Its programmable mesoporous structure is achieved by precisely controlling the desilication-recrystallization kinetics. Tunable mesopores with precise diameters of 4-6 nm and 20-30 nm were fabricated by controlling cavity expansion through temporal modulation (2-32 h) of a time-dependent synthesis process. Detailed analysis of drug loading and release profiles revealed that although pore structure modification did not significantly alter drug loading efficiency (DLE), it induced a slight but consistent improvement in drug release rate as pore size increased. Systematic biocompatibility evaluation was conducted through an in vitro human colonic epithelial tissue model complemented by the KM mice in vivo studies. Histopathological analysis confirmed Silicalite-1-X caused minimal cytotoxicity and oxidative stress in healthy colon tissue, preserved mucus secretion, and showed no systemic toxicity. Furthermore, Doxorubicin (DOX) loaded Silicalite-1-X platform (Silicalite-1-DOX-X) exhibited dose-dependent cytotoxic efficacy against colorectal carcinoma in vitro models, confirming its anti-tumor therapeutic potential. Our findings provide a framework for engineering molecular sieves with tunable porosity and a platform for expanding their multifunctional applications in advanced materials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinColorectal NeoplasmsSilicatesAntibiotics, AntineoplasticDrug Delivery SystemsDrug CarriersPorosityHumansAnimalsMiceCell ProliferationParticle SizeDrug LiberationCrystallizationDrug Screening Assays, AntitumorCell SurvivalSilicon DioxideSurface PropertiesCell Line, Tumor

Stichwörter der Autor:innen

Anti-tumor capacityBiocompatibilityDesilication-recrystallisationDoxorubicinSilica-based molecular sieve

Substanzen

DoxorubicinSilicatesAntibiotics, AntineoplasticSilicon DioxideDrug Carriers

Autor:innen und Institutionen

  • Academy of Medical Sciences, Shanxi Medical University, Jinzhong 030600, PR China.
  • School of Forensic Medicine, Shanxi Medical University, Jinzhong 030600, PR China; Shanxi Key Laboratory of Forensic Medicine, Jinzhong 030600, PR China.
  • The First Clinical Medical School, Shanxi Medical University, Taiyuan 030001, PR China.
  • School of Industry, Shanxi Medical University, Jinzhong 030600, PR China.
  • Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030001, PR China.
  • Academy of Medical Sciences, Shanxi Medical University, Jinzhong 030600, PR China; School of Industry, Shanxi Medical University, Jinzhong 030600, PR China; School of Nursing, Shanxi Medical University, Taiyuan 030001,…

Förderung

  • Shanxi Medical University

Zitieren

APA

Li, W., Shao, J., Zhang, C., Cao, G., Yan, Y., Han, Q., Yu, H., Wei, Y., Zhang, W., Zheng, J., & Guo, Z. (2026). Facile synthesis of Silicalite-1 with tunable porous architectures via desilication-recrystallization: Enhanced Doxorubicin delivery and inhibited growth against colorectal cancer. Colloids and Surfaces B: Biointerfaces, 257, 115136. https://doi.org/10.1016/j.colsurfb.2025.115136

Vancouver

Li W, Shao J, Zhang C, Cao G, Yan Y, Han Q, et al. Facile synthesis of Silicalite-1 with tunable porous architectures via desilication-recrystallization: Enhanced Doxorubicin delivery and inhibited growth against colorectal cancer. Colloids and Surfaces B: Biointerfaces. 2026;257:115136. doi:10.1016/j.colsurfb.2025.115136

BibTeX
@article{Li2026,
  author = {Li, Wenjing and Shao, Juan and Zhang, Chuxin and Cao, Guodong and Yan, Yitao and Han, Qiongyi and Yu, Huimei and Wei, Yingying and Zhang, Wenbo and Zheng, Jie and Guo, Zhongyuan},
  title = {Facile synthesis of Silicalite-1 with tunable porous architectures via desilication-recrystallization: Enhanced Doxorubicin delivery and inhibited growth against colorectal cancer},
  journal = {Colloids and Surfaces B: Biointerfaces},
  year = {2026},
  volume = {257},
  pages = {115136},
  doi = {10.1016/j.colsurfb.2025.115136}
}
Kostenlos starten →